Form D · Other

Strados Labs, Inc.

Philadelphia, PA · CIK 0001775771

Offering snapshot reported Jun 6, 2022 · SEC filing

Reported sold
$585K
Offering amount: $3M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 20, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 6, 2022Initial$585,000No comparison12SEC filing
Nov 5, 2021Amendment$3,136,180$1,206,180vs Jul 30, 202129SEC filing
Jul 30, 2021Initial$1,930,000No comparisonNot reportedSEC filing
May 27, 2020Initial$250,000No comparison1SEC filing
May 9, 2019Initial$1,858,880No comparison16SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-448145

Source: Form D, filed Jun 6, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Ball Director
Steve Bishop Director
Nicholas Delmonico Director, Executive
Alex Levit Director
Richard Powers Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
1315 Walnut Street Suite 1101
Philadelphia, PA, 19107